Hologic Acquires Endomagnetics (Endomag) for About $310 Million

Endologix Acquires Pounce Thrombectomy System From Surmodics

May 20, 2026

Medical Devices

Endologix, a privately held medical device company, announced it will acquire the Pounce Thrombectomy System from Surmodics. The FDA-cleared, fully mechanical peripheral thrombectomy platform is intended to complement Endologix’s existing vascular intervention portfolio and expand the continuum of care for patients with peripheral vascular disease.

Blackstone and TPG Acquire Hologic in $18.3B Take-Private

October 22, 2025

Medical Devices

Hologic agreed to be acquired by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share and approximately $18.3 billion enterprise value. The deal provides $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3 per share tied to Breast Health revenue milestones in fiscal 2026 and 2027.

Hologic Acquires Gynesonics

January 6, 2025

Medical Devices

Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.

Haemonetics to Acquire Attune Medical

March 5, 2024

Healthcare Services

Haemonetics Corporation has entered into a definitive agreement to acquire privately held Attune Medical, the manufacturer of the ensoETM proactive esophageal cooling device used during RF cardiac ablation procedures. The deal calls for an upfront cash payment of $160 million at closing, plus additional contingent consideration tied to sales growth and other milestones, and is expected to close in Haemonetics’ fiscal first quarter of 2025.

Hologic Acquires Bolder Surgical for Approximately $160 Million

October 14, 2021

Healthcare Services

Hologic, Inc. has completed its previously announced acquisition of Bolder Surgical, a privately held U.S. provider of advanced energy vessel sealing surgical devices, for approximately $160 million. The deal expands Hologic’s surgical portfolio with laparoscopic vessel sealing, dividing and dissection tools and enables broader use of Bolder’s devices by OB/GYN specialists.

Hologic, Inc. Acquires Mobidiag Oy

June 17, 2021

Medical Devices

Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.